AFC Energy PLC (LON:AFC) has unveiled four new brands as its inaugural product line of hydrogen power technologies. The AIM-listed firm is launching HydroX-Cell(L), a zero-emission, high efficiency and low-cost alkaline fuel cell utilising a liquid electrolyte configured in 10 kilowatt (kW) modules, to be used in large scale industrial applications utilising lower grades of hydrogen.
Jubilee Metals Group PLC (LON:JLP) is to extend its rights over the chrome contained in the historic tailings at the Inyoni project in South Africa, in a deal valued at approximately US$16.4mln.The move comes after a major ferrochrome producer exercised its right to sell.
AdEPT Technology Group PLC (LON:ADT) has been granted “diamond” reseller partner status by US communications group Avaya, one of only eight such partners in the UK. AdEPT and Avaya have been cooperating for more than 20 years, with Avaya’s solutions forming an “important part” of AdEPT’s product portfolio.
Amryt Pharma PLC (LON:AMYT) chief executive, Dr Joe Wiley, described as “momentous and transformational” the first nine months of the company’s financial year. It is a period in which it completed the acquisition of Aegerion Pharmaceuticals Inc, which gave it full control of the Lojuxta cholesterol treatment.
Arc Minerals Ltd (LON:ARCM), the Zambian-focussed copper exploration and development company, has received additional near-surface, high-grade copper assays from its maiden diamond drill exploration programme at the Cheyeza East target in Zambia. Among the highlights were 1.44% copper over 20 metres from a depth of 34.5 metres and 1.2% copper 14 metres from a depth of 38 metres.
Verona Pharma PLC (LON:VRP) chief executive, Jan-Anders Karlsson has said he is “very excited” by the potential of the company’s treatment for chronic obstructive pulmonary disease (COPD). Ensifentrine is an inhaled drug with a dual-action: it is both a bronchodilator – relaxes the lung muscles – and an anti-inflammatory. The second part of a phase II study of Verona’s dry powder inhaler formulation met all of its primary and secondary lung function targets, or endpoints.
Cadogan Petroleum Plc (LON:CAD) has moved a step closer to renewing the licence for its main producing asset in Ukraine. The regional Council of L’viv has approved the application for a 20-year production license for the Blazhiv field (formerly Monastyretska) and has notified the licensing authority (SGS). This is the last of the intermediate approvals required for the SGS to issue its final decision on the Blazhiv field license award, said Cadogan.
Plexus Holdings Plc’s (LON:POS) increased revenues but racked up higher losses as it adjusted following a switch in strategy last year. The profitable wellhead rental business was sold in 2018, which meant statutory losses rising to £3.3mln from £372,000 in the year to June. Revenues in the ongoing business rose to £3.61mln from £318,000, as the new strategy of licensing its wellhead IP gained momentum.
Sareum Holdings PLC (LON:SAR), the specialist small molecule drug development business, noted that Sierra Oncology, Inc. – the licence holder advancing its clinical cancer candidate SRA737 – revealed with its third-quarter results that it is conducting a campaign intended to seek non-dilutive strategic options to support the future advancement of SRA737, based on its decision to prioritise its resources on the development of its lead candidate momelotinib.
Shefa Gems Ltd (LON:SEFA) has entered into a convertible loan agreement valued at US$200,000 with a shareholder of the company. The money will be used for working capital purposes and to fund the continued development of the Kishon Mid-Reach gemstone project in Israel. The loan, together with rolled-up interest at 5%, is convertible into shares at 5p each at any time until 31 March 2021.
Baker Steel Resources Trust Limited (LON:BSRT) announced that its unaudited net asset value per share as at 31 October 2019 was 68.8p. The group said that was a 1.4% decrease against the NAV as at 30 September 2019, primarily due to the rise in the sterling exchange rate which was partially offset by a rise in the share price of Polymetal International PLC (LON:POLY).
IXICO PLC (LON:IXI), the AI data analytics company, announced that it is scheduled to attend and present scientific posters at two conferences in the USA in November 2019. It said it will present a poster at the Huntington Study Group 2019 Annual Meeting, being held in Sacramento, California, entitled “A Fully Automatic Pipeline for Estimation of Putamen and Caudate Volume” on 7 November at 5pm and on 8 November at 3.15pm. In addition, the firm added, it will present an abstract at the International Ataxia Research Conference 2019, being held in Washington DC, entitled “Fully automated measurement of brainstem and cerebellar volume: imaging endpoint for Ataxia, PSP and FA in multicenterclinical trial studies” on 14 November at 5.30pm and on 15 November at 12.30pm.